Guidance on the interpretation of faecal calprotectin levels in children
Fig 2
A Proportion of patients with newly diagnosed IBD (red) and without IBD (green) according to their FCP of </≥ 50 μg/g, </≥ 250 μg/g and </≥ 600 μg/g. The difference between IBD diagnoses in patients with FCP < and ≥ 250 μg/g as well as in those with FCP < and ≥ 600 μg/g is statistically significant (p < 0.05). B Proportion of patients with/without IBD who were referred due to and not due to their elevated FCP (Ref. FCP and Ref. not FCP, respectively). C Proportion of patients with/without IBD and referred due to their FCP of 50–250 μg/g.